Why is Bandaram Pharma falling/rising?

As of 07-Jul, Bandaram Pharma Packtech Ltd is experiencing a price increase, with a current price of 41.89, reflecting a change of 0.39 (0.94%) upward. The stock has shown strong performance recently, gaining 9.46% over the last four days and outperforming its sector by 2.03%. In the past week, the stock has risen by 4.73%, and over the last month, it has increased by 10.27%. Despite these positive short-term movements, the stock's year-to-date performance is down by 5.65%, and its long-term fundamentals show weaknesses, including a high Debt to EBITDA ratio and a low average Return on Capital Employed (ROCE) of 5.74%.
In the broader market context, Bandaram Pharma's recent gains contrast with the Sensex, which has seen a slight decline of 0.20% over the past week. While the stock has outperformed the market significantly over the past year with a return of 32.35% compared to the BSE500's 1.74%, concerns about its long-term financial health may temper investor enthusiasm. The company's flat results in March, including a significant drop in net sales, highlight potential vulnerabilities that could impact future performance. Overall, while the stock is currently rising, its long-term outlook remains uncertain due to fundamental weaknesses.